{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T15:37:10Z","timestamp":1777217830495,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u201cScientific Research Climbing Plan\u201d of Hunan Cancer Hospital","award":["YF2021003"],"award-info":[{"award-number":["YF2021003"]}]},{"name":"\u201cScientific Research Climbing Plan\u201d of Hunan Cancer Hospital","award":["IIT2021006]"],"award-info":[{"award-number":["IIT2021006]"]}]},{"name":"the Clinical Research Center For Gastrointestinal Cancer In Hunan Province","award":["2021SK4016"],"award-info":[{"award-number":["2021SK4016"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203836"],"award-info":[{"award-number":["82203836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12651-x","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T16:42:15Z","timestamp":1755103335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome"],"prefix":"10.1038","volume":"15","author":[{"given":"Lin","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"12651_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"12651_CR2","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1038\/s41467-020-16711-w","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin, Y. et al. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer. Nat. Commun. 11, 3175 (2020).","journal-title":"Nat. Commun."},{"key":"12651_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel, E. M., Brand, R. E. & Goggins, M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology 164, 752\u2013765 (2023).","journal-title":"Gastroenterology"},{"key":"12651_CR4","doi-asserted-by":"publisher","first-page":"100328","DOI":"10.1016\/j.modpat.2023.100328","volume":"36","author":"E Karamitopoulou","year":"2023","unstructured":"Karamitopoulou, E. Emerging prognostic and predictive factors in pancreatic Cancer. Mod. Pathol. 36, 100328 (2023).","journal-title":"Mod. Pathol."},{"key":"12651_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1200\/JOP.2016.017376","volume":"13","author":"EP Balaban","year":"2017","unstructured":"Balaban, E. P., Mangu, P. B. & Yee, N. S. Locally advanced unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline summary. J. Oncol. Pract. 13, 265\u2013269 (2017).","journal-title":"J. Oncol. Pract."},{"key":"12651_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy, T. et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 34, 987\u20131002 (2023).","journal-title":"Ann. Oncol."},{"key":"12651_CR7","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1200\/JCO.19.02274","volume":"38","author":"E Versteijne","year":"2020","unstructured":"Versteijne, E. et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial. J. Clin. Oncol. 38, 1763\u20131773 (2020).","journal-title":"J. Clin. Oncol."},{"key":"12651_CR8","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1200\/JCO.19.03318","volume":"38","author":"EM O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly, E. M. & Ferrone, C. Neoadjuvant or adjuvant therapy for resectable or borderline resectable pancreatic cancer: which is preferred?? J. Clin. Oncol. 38, 1757\u20131759 (2020).","journal-title":"J. Clin. Oncol."},{"key":"12651_CR9","unstructured":"Huber, M. et al. The immune microenvironment in pancreatic Cancer. Int. J. Mol. Sci. 21, (2020)."},{"key":"12651_CR10","doi-asserted-by":"crossref","unstructured":"Poyia, F., Neophytou, C. M., Christodoulou, M. I. & Papageorgis, P. The role of tumor microenvironment in pancreatic cancer immunotherapy: current status and future perspectives. Int. J. Mol. Sci. 25, (2024).","DOI":"10.3390\/ijms25179555"},{"key":"12651_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-022-00732-2","volume":"46","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Zhang, J., Liang, X. & Ding, J. Research advances and treatment perspectives of pancreatic adenosquamous carcinoma. Cell. Oncol. (Dordr). 46, 1\u201315 (2023).","journal-title":"Cell. Oncol. (Dordr)"},{"key":"12651_CR12","doi-asserted-by":"publisher","first-page":"e1433517","DOI":"10.1080\/2162402X.2018.1433517","volume":"7","author":"S Wu","year":"2018","unstructured":"Wu, S. et al. C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II\/III gastric cancer. Oncoimmunology 7, e1433517 (2018).","journal-title":"Oncoimmunology"},{"key":"12651_CR13","doi-asserted-by":"crossref","unstructured":"Wang, L. et al. Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. Elife 11, (2022).","DOI":"10.7554\/eLife.80150"},{"key":"12651_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fbioe.2020.00196","volume":"8","author":"Z Tong","year":"2020","unstructured":"Tong, Z. et al. Development, validation and comparison of artificial neural network models and logistic regression models predicting survival of unresectable pancreatic Cancer. Front. Bioeng. Biotechnol. 8, 196 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"12651_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-020-01151-3","volume":"19","author":"JQ Fan","year":"2020","unstructured":"Fan, J. Q. et al. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma. Mol. Cancer. 19, 32 (2020).","journal-title":"Mol. Cancer"},{"key":"12651_CR16","doi-asserted-by":"crossref","unstructured":"Wang, H., You, S., Fang, M. & Fang, Q. Recognition of immune microenvironment landscape and immune-Related prognostic genes in breast Cancer. Biomed. Res. Int. 3909416, 2020. (2020).","DOI":"10.1155\/2020\/3909416"},{"key":"12651_CR17","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/s12885-021-08629-3","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. BMC Cancer. 21, 905 (2021).","journal-title":"BMC Cancer"},{"key":"12651_CR18","doi-asserted-by":"publisher","first-page":"1747345","DOI":"10.1080\/2162402X.2020.1747345","volume":"9","author":"SK Bisheshar","year":"2020","unstructured":"Bisheshar, S. K., De Ruiter, E. J., Devriese, L. A. & Willems, S. M. The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Oncoimmunology 9, 1747345 (2020).","journal-title":"Oncoimmunology"},{"key":"12651_CR19","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1038\/s41467-019-12628-1","volume":"10","author":"K Esfahani","year":"2019","unstructured":"Esfahani, K. et al. Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 Blockade in renal transplantation. Nat. Commun. 10, 4712 (2019).","journal-title":"Nat. Commun."},{"key":"12651_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol. Cancer. 23, 108 (2024).","journal-title":"Mol. Cancer"},{"key":"12651_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12943-023-01800-3","volume":"22","author":"X Chu","year":"2023","unstructured":"Chu, X., Tian, W., Wang, Z., Zhang, J. & Zhou, R. Co-inhibition of TIGIT and PD-1\/PD-L1 in Cancer immunotherapy: mechanisms and clinical trials. Mol. Cancer. 22, 93 (2023).","journal-title":"Mol. Cancer"},{"key":"12651_CR22","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1021\/acsnano.8b09613","volume":"13","author":"F Fontana","year":"2019","unstructured":"Fontana, F. et al. Biohybrid vaccines for improved treatment of aggressive melanoma with checkpoint inhibitor. ACS Nano. 13, 6477\u20136490 (2019).","journal-title":"ACS Nano"},{"key":"12651_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","volume":"9","author":"SJ Wang","year":"2023","unstructured":"Wang, S. J., Dougan, S. K. & Dougan, M. Immune mechanisms of toxicity from checkpoint inhibitors. Trends Cancer. 9, 543\u2013553 (2023).","journal-title":"Trends Cancer"},{"key":"12651_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ccell.2023.01.004","volume":"41","author":"B Virassamy","year":"2023","unstructured":"Virassamy, B. et al. Intratumoral CD8(+) T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer. Cancer Cell. 41, 585\u2013601 (2023). e588.","journal-title":"Cancer Cell."},{"key":"12651_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 Blockade. Science 357, 409\u2013413 (2017).","journal-title":"Science"},{"key":"12651_CR26","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1078-0432.CCR-16-2318","volume":"23","author":"BA Johnson","year":"2017","unstructured":"Johnson, B. A. 3, Yarchoan, M., Lee, V., Laheru, D. A., Jaffee, E. M. & rd,, and Strategies for increasing pancreatic tumor immunogenicity. Clin. Cancer Res. 23, 1656\u20131669 (2017).","journal-title":"Clin. Cancer Res."},{"key":"12651_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccell.2015.09.020","volume":"28","author":"AV Biankin","year":"2015","unstructured":"Biankin, A. V. & Maitra, A. Subtyping pancreatic Cancer. Cancer Cell. 28, 411\u2013413 (2015).","journal-title":"Cancer Cell."},{"key":"12651_CR28","doi-asserted-by":"publisher","first-page":"998266","DOI":"10.3389\/fimmu.2022.998266","volume":"13","author":"Y Qin","year":"2022","unstructured":"Qin, Y. et al. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation. Front. Immunol. 13, 998266 (2022).","journal-title":"Front. Immunol."},{"key":"12651_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","volume":"265","author":"SM Man","year":"2015","unstructured":"Man, S. M. & Kanneganti, T. D. Regulation of inflammasome activation. Immunol. Rev. 265, 6\u201321 (2015).","journal-title":"Immunol. Rev."},{"key":"12651_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.coi.2020.11.006","volume":"68","author":"A Ta","year":"2021","unstructured":"Ta, A. & Vanaja, S. K. Inflammasome activation and evasion by bacterial pathogens. Curr. Opin. Immunol. 68, 125\u2013133 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"12651_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2016.05.001","volume":"138","author":"HM Hoffman","year":"2016","unstructured":"Hoffman, H. M. & Broderick, L. The role of the inflammasome in patients with autoinflammatory diseases. J. Allergy Clin. Immunol. 138, 3\u201314 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"12651_CR32","doi-asserted-by":"publisher","first-page":"1195572","DOI":"10.3389\/fimmu.2023.1195572","volume":"14","author":"Z Deng","year":"2023","unstructured":"Deng, Z. et al. The roles of inflammasomes in cancer. Front. Immunol. 14, 1195572 (2023).","journal-title":"Front. Immunol."},{"key":"12651_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. AIM2 forms a complex with Pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597, 415\u2013419 (2021).","journal-title":"Nature"},{"key":"12651_CR34","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/eji.201848070","volume":"49","author":"BR Sharma","year":"2019","unstructured":"Sharma, B. R., Karki, R. & Kanneganti, T. D. Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur. J. Immunol. 49, 1998\u20132011 (2019).","journal-title":"Eur. J. Immunol."},{"key":"12651_CR35","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.7150\/ijbs.79853","volume":"19","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. AIM2 promotes renal cell carcinoma progression and Sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis. Int. J. Biol. Sci. 19, 1266\u20131283 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"12651_CR36","doi-asserted-by":"crossref","unstructured":"Han, C. et al. The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation. Sci. Immunol. 6, (2021).","DOI":"10.1126\/sciimmunol.abc6998"},{"key":"12651_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/iid3.443","volume":"9","author":"H Zhu","year":"2021","unstructured":"Zhu, H. et al. The complex role of AIM2 in autoimmune diseases and cancers. Immun. Inflamm. Dis. 9, 649\u2013665 (2021).","journal-title":"Immun. Inflamm. Dis."},{"key":"12651_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2326-6066.CIR-16-0269","volume":"5","author":"R Karki","year":"2017","unstructured":"Karki, R., Man, S. M. & Kanneganti, T. D. Inflammasomes and Cancer. Cancer Immunol. Res. 5, 94\u201399 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"12651_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature07710","volume":"458","author":"T Fernandes-Alnemri","year":"2009","unstructured":"Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509\u2013513 (2009).","journal-title":"Nature"},{"key":"12651_CR40","doi-asserted-by":"publisher","first-page":"102322","DOI":"10.1016\/j.redox.2022.102322","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated DsDNA release and AIM2 inflammasome activation. Redox Biol. 52, 102322 (2022).","journal-title":"Redox Biol."},{"key":"12651_CR41","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1038\/s41418-022-01033-9","volume":"29","author":"C Baatarjav","year":"2022","unstructured":"Baatarjav, C. et al. dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury. Cell. Death Differ. 29, 2487\u20132502 (2022).","journal-title":"Cell. Death Differ."},{"key":"12651_CR42","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1126\/science.aaf7532","volume":"354","author":"B Hu","year":"2016","unstructured":"Hu, B. et al. The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science 354, 765\u2013768 (2016).","journal-title":"Science"},{"key":"12651_CR43","doi-asserted-by":"publisher","first-page":"e1160182","DOI":"10.1080\/2162402X.2016.1160182","volume":"5","author":"M Zhang","year":"2016","unstructured":"Zhang, M. et al. AIM2 inflammasome mediates Arsenic-induced secretion of IL-1 beta and IL-18. Oncoimmunology 5, e1160182 (2016).","journal-title":"Oncoimmunology"},{"key":"12651_CR44","doi-asserted-by":"publisher","first-page":"607881","DOI":"10.3389\/fimmu.2020.607881","volume":"11","author":"G Tezcan","year":"2020","unstructured":"Tezcan, G. et al. Therapeutic potential of Pharmacological targeting NLRP3 inflammasome complex in Cancer. Front. Immunol. 11, 607881 (2020).","journal-title":"Front. Immunol."},{"key":"12651_CR45","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/s41401-023-01079-6","volume":"44","author":"SA Kovacs","year":"2023","unstructured":"Kovacs, S. A., Fekete, J. T. & Gyorffy, B. Predictive biomarkers of immunotherapy response with Pharmacological applications in solid tumors. Acta Pharmacol. Sin. 44, 1879\u20131889 (2023).","journal-title":"Acta Pharmacol. Sin"},{"key":"12651_CR46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/iid3.363","volume":"8","author":"F Bu","year":"2020","unstructured":"Bu, F. et al. A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients. Immun. Inflamm. Dis. 8, 713\u2013726 (2020).","journal-title":"Immun. Inflamm. Dis."},{"key":"12651_CR47","doi-asserted-by":"crossref","unstructured":"Wu, G. et al. Identification of prognostic Immune-Related genes in pancreatic adenocarcinoma and establishment of a prognostic nomogram: A bioinformatic study. Biomed. Res. Int.  1346045, 2020. (2020).","DOI":"10.1155\/2020\/1346045"},{"key":"12651_CR48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung, V. et al. AIM2 recognizes cytosolic DsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514\u2013518 (2009).","journal-title":"Nature"},{"key":"12651_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-981-13-9367-9_7","volume":"1172","author":"B Wang","year":"2019","unstructured":"Wang, B., Tian, Y. & Yin, Q. AIM2 inflammasome assembly and signaling. Adv. Exp. Med. Biol. 1172, 143\u2013155 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"12651_CR50","doi-asserted-by":"publisher","first-page":"1211730","DOI":"10.3389\/fimmu.2023.1211730","volume":"14","author":"ZH Chew","year":"2023","unstructured":"Chew, Z. H. et al. Macrophage IL-1beta contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironment. Front. Immunol. 14, 1211730 (2023).","journal-title":"Front. Immunol."},{"key":"12651_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ni.1864","volume":"11","author":"VA Rathinam","year":"2010","unstructured":"Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11, 395\u2013402 (2010).","journal-title":"Nat. Immunol."},{"key":"12651_CR52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jsb.2017.08.001","volume":"200","author":"B Wang","year":"2017","unstructured":"Wang, B. & Yin, Q. AIM2 inflammasome activation and regulation: A structural perspective. J. Struct. Biol. 200, 279\u2013282 (2017).","journal-title":"J. Struct. Biol."},{"key":"12651_CR53","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1349-7006.2012.02211.x","volume":"103","author":"Y Kondo","year":"2012","unstructured":"Kondo, Y. et al. Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation. Cancer Sci. 103, 782\u2013790 (2012).","journal-title":"Cancer Sci."},{"key":"12651_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12967-023-04825-w","volume":"22","author":"HW Chiu","year":"2024","unstructured":"Chiu, H. W. et al. AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1\/NF-kappaB activation in oral squamous cell carcinoma. J. Transl Med. 22, 13 (2024).","journal-title":"J. Transl Med."},{"key":"12651_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/cas.15584","volume":"114","author":"JQ Zheng","year":"2023","unstructured":"Zheng, J. Q. et al. AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma. Cancer Sci. 114, 306\u2013320 (2023).","journal-title":"Cancer Sci."},{"key":"12651_CR56","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1186\/s12885-022-09927-0","volume":"22","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer. BMC Cancer. 22, 879 (2022).","journal-title":"BMC Cancer"},{"key":"12651_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/JP9.0000000000000175","volume":"7","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. J. Pancreatol. 7, 119\u2013130 (2024).","journal-title":"J. Pancreatol"},{"key":"12651_CR58","doi-asserted-by":"publisher","first-page":"e82282","DOI":"10.1371\/journal.pone.0082282","volume":"8","author":"A Bera","year":"2013","unstructured":"Bera, A., Zhao, S., Cao, L., Chiao, P. J. & Freeman, J. W. Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR\/NF-kappaB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells. PLoS One. 8, e82282 (2013).","journal-title":"PLoS One"},{"key":"12651_CR59","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425 (2015).","journal-title":"Cell. Syst."},{"key":"12651_CR60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fgene.2020.00607","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Bioinformatics analysis finds immune gene markers related to the prognosis of bladder Cancer. Front. Genet. 11, 607 (2020).","journal-title":"Front. Genet."},{"key":"12651_CR61","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/cns.12171","volume":"20","author":"ZS Bao","year":"2014","unstructured":"Bao, Z. S. et al. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling. CNS Neurosci. Ther. 20, 112\u2013118 (2014).","journal-title":"CNS Neurosci. Ther."},{"key":"12651_CR62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omics: J. Integr. Biology. 16, 284\u2013287 (2012).","journal-title":"Omics: J. Integr. Biology"},{"key":"12651_CR63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"12651_CR64","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41420-024-02197-8","volume":"10","author":"L Liang","year":"2024","unstructured":"Liang, L. et al. CircGSK3beta mediates PD-L1 transcription through miR-338-3p\/PRMT5\/H3K4me3 to promote breast cancer cell immune evasion and tumor progression. Cell. Death Discov. 10, 426 (2024).","journal-title":"Cell. Death Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12651-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:09:53Z","timestamp":1757390993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12651-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12651"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12651-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29733"}}